Exercise-Induced Irisin Decreases Inflammation and Improves NAFLD by Competitive Binding with MD2
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Exercise-Induced Irisin Decreases Inflammation and Improves NAFLD by Competitive Binding with MD2
Authors
Keywords
-
Journal
Cells
Volume 10, Issue 12, Pages 3306
Publisher
MDPI AG
Online
2021-11-29
DOI
10.3390/cells10123306
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Irisin ameliorates endoplasmic reticulum stress and liver fibrosis through inhibiting PERK-mediated destabilization of HNRNPA1 in hepatic stellate cells
- (2021) Xin Liao et al. BIOLOGICAL CHEMISTRY
- Effects of Long-Term DHA Supplementation and Physical Exercise on Non-Alcoholic Fatty Liver Development in Obese Aged Female Mice
- (2021) Jinchunzi Yang et al. Nutrients
- Associations of Circulating Irisin with FNDC5 Expression in Fat and Muscle in Type 1 and Type 2 Diabetic Mice
- (2021) Songling Jiang et al. Biomolecules
- NLRP3-mediated pyroptosis aggravates pressure overload-induced cardiac hypertrophy, fibrosis, and dysfunction in mice: cardioprotective role of irisin
- (2021) Rongchuan Yue et al. Cell Death Discovery
- The Role of Gut-Derived Lipopolysaccharides and the Intestinal Barrier in Fatty Liver Diseases
- (2021) Lingxuan An et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Hepatic FNDC5 is a potential local protective factor against Non-Alcoholic Fatty Liver
- (2020) Clémence M. Canivet et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Metabolic inflammation as an instigator of fibrosis during non-alcoholic fatty liver disease
- (2020) Angeliki Katsarou et al. WORLD JOURNAL OF GASTROENTEROLOGY
- MD2 activation by direct AGE interaction drives inflammatory diabetic cardiomyopathy
- (2020) Yi Wang et al. Nature Communications
- MD-2 as a possible therapeutic target for atherosclerosis
- (2020) Shuang Chen et al. EBioMedicine
- Irisin Protects Brain against Ischemia/Reperfusion Injury through Suppressing TLR4/MyD88 Pathway
- (2020) Qian Yu et al. CEREBROVASCULAR DISEASES
- Exercise and intestinal permeability: another form of exercise-induced hormesis?
- (2020) Bryant H. Keirns et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Irisin alleviates LPS-induced liver injury and inflammation through inhibition of NLRP3 inflammasome and NF-κB signaling
- (2020) Qian Li et al. JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION
- Metabolism-Associated Molecular Patterns (MAMPs)
- (2020) Xu Wang et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Fibroblast growth factor 2 exacerbates inflammation in adipocytes through NLRP3 inflammasome activation
- (2020) De-Li ZhuGe et al. ARCHIVES OF PHARMACAL RESEARCH
- Role of Myokines in Regulating Skeletal Muscle Mass and Function
- (2019) Jong Han Lee et al. Frontiers in Physiology
- Irisin Is Controlled by Farnesoid X Receptor and Regulates Cholesterol Homeostasis
- (2019) Hong Li et al. Frontiers in Pharmacology
- Apigenin ameliorates HFD-induced NAFLD through regulation of the XO/NLRP3 pathways
- (2019) Yanan Lv et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Silybin inhibits NLRP3 inflammasome assembly through the NAD+/SIRT2 pathway in mice with nonalcoholic fatty liver disease
- (2018) Bangling Zhang et al. FASEB JOURNAL
- Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors
- (2018) Hyeonwoo Kim et al. CELL
- Molecular pathways of nonalcoholic fatty liver disease development and progression
- (2018) Fernando Bessone et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Anti-Inflammatory Properties of Irisin, Mediator of Physical Activity, Are Connected with TLR4/MyD88 Signaling Pathway Activation
- (2017) Agnieszka Irena Mazur-Bialy et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Inhibition of MD2-dependent inflammation attenuates the progression of non-alcoholic fatty liver disease
- (2017) Yali Zhang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Blockade of myeloid differentiation protein 2 prevents obesity-induced inflammation and nephropathy
- (2017) Qilu Fang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Current and future pharmacological therapies for NAFLD/NASH
- (2017) Yoshio Sumida et al. JOURNAL OF GASTROENTEROLOGY
- Treatment of NAFLD with diet, physical activity and exercise
- (2017) Manuel Romero-Gómez et al. JOURNAL OF HEPATOLOGY
- The ClusPro web server for protein–protein docking
- (2017) Dima Kozakov et al. Nature Protocols
- Physiology and role of irisin in glucose homeostasis
- (2017) Nikolaos Perakakis et al. Nature Reviews Endocrinology
- Clinical epidemiology and disease burden of nonalcoholic fatty liver disease
- (2017) Brandon J Perumpail et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Animal Models of Nonalcoholic Fatty Liver Disease—A Starter’s Guide
- (2017) Mikhaïl Van Herck et al. Nutrients
- The ever-expanding myokinome: discovery challenges and therapeutic implications
- (2016) Martin Whitham et al. NATURE REVIEWS DRUG DISCOVERY
- Exercise and Adipose Tissue Macrophages: New Frontiers in Obesity Research?
- (2016) Jorming Goh et al. Frontiers in Endocrinology
- Irisin Inhibits Hepatic Cholesterol Synthesis via AMPK-SREBP2 Signaling
- (2016) Hong Tang et al. EBioMedicine
- Hepatic TLR4 signaling in obese NAFLD
- (2015) Torfay Sharifnia et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- New role of irisin in hepatocytes: The protective effect of hepatic steatosis in vitro
- (2015) Min-Jung Park et al. CELLULAR SIGNALLING
- Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytes
- (2015) T.-Y. Liu et al. CLINICAL SCIENCE
- Irisin improves fatty acid oxidation and glucose utilization in type 2 diabetes by regulating the AMPK signaling pathway
- (2015) C Xin et al. INTERNATIONAL JOURNAL OF OBESITY
- Nonalcoholic fatty liver disease
- (2015) Elizabeth M. Brunt et al. Nature Reviews Disease Primers
- Irisin stimulates muscle growth-related genes and regulates adipocyte differentiation and metabolism in humans
- (2014) J Y Huh et al. INTERNATIONAL JOURNAL OF OBESITY
- Irisin Stimulates Browning of White Adipocytes Through Mitogen-Activated Protein Kinase p38 MAP Kinase and ERK MAP Kinase Signaling
- (2013) Y. Zhang et al. DIABETES
- The Structure of Irisin Reveals a Novel Intersubunit β-Sheet Fibronectin Type III (FNIII) Dimer
- (2013) Maria A. Schumacher et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- FNDC5/Irisin Is Not Only a Myokine but Also an Adipokine
- (2013) Arturo Roca-Rivada et al. PLoS One
- A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis
- (2012) Pontus Boström et al. NATURE
- Regular physical exercise training assists in preventing type 2 diabetes development: focus on its antioxidant and anti-inflammatory properties
- (2011) Edite Teixeira-Lemos et al. Cardiovascular Diabetology
- Elevated endotoxin levels in non-alcoholic fatty liver disease
- (2010) Alison L Harte et al. Journal of Inflammation-London
- Insulin resistance, inflammation, and non-alcoholic fatty liver disease
- (2008) Herbert Tilg et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started